Report Library
View More
CAR-T: From Bench to Billion-Dollar...
September 10, 2026
Alpha-1 Antitrypsin Deficiency (AAT...
September 7, 2026
Alpha-1 Antitrypsin Deficiency (AAT...
September 7, 2026
Alpha-1 Antitrypsin Deficiency (AAT...
September 6, 2026
Datamonitor Healthcare CV&Met: Veno...
September 3, 2026
Datamonitor Healthcare CV&Met: Atri...
September 3, 2026
Key Potential Drug Launches in 2027
September 1, 2026
HER2-Positive Breast Cancer KOL Int...
August 26, 2026
Datamonitor Healthcare CV&Met: Chem...
August 26, 2026
Datamonitor Healthcare Oncology: Sm...
August 26, 2026
Datamonitor Healthcare I&I: Glaucom...
August 26, 2026
HER2-Positive Breast Cancer KOL Int...
August 25, 2026
HER2-Positive Breast Cancer KOL Int...
August 24, 2026
HER2-Positive Breast Cancer KOL Int...
August 23, 2026
Datamonitor Healthcare Other: Erect...
August 19, 2026
Datamonitor Healthcare Other: Hypog...
August 19, 2026
Datamonitor Healthcare CV&Met: Amyl...
August 19, 2026
Datamonitor Healthcare Oncology: Tu...
August 19, 2026
Datamonitor Healthcare CNS: Neuropa...
August 19, 2026
Datamonitor Healthcare CNS Disease ...
August 13, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 9/8/26 | Bristol Myers Squibb (BMY) | Arlo-cel for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/2/26 | Teva Pharmaceutical Industries (TEVA) | TEV-53408 for Celiac Disease | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/2/26 | Jiangsu Hengrui Pharmaceuticals (600276:SS) | SHR-1918 for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/2/26 | Jiangsu Hengrui Pharmaceuticals (600276:SS) | SHR-1918 for Homozygous Familial Hypercholesterolemia (HoFH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/1/26 | Alumis (ALMS) | envudeucitinib for Systemic Lupus Erythematosus (SLE) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 07/31/2025 | Subscribers Only | Subscribers Only | Regulatory - sNDA/sBLA Filing |
| 09/30/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Trial Completion |
| 10/28/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/31/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 11/11/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |